Literature DB >> 14575317

Adenosine and cardioprotection during reperfusion--an overview.

Martín Donato1, Ricardo J Gelpi.   

Abstract

Ischemic heart disease includes a number of entities that have been grouped in accordance with physiopathology and evolutive criteria. In recent years 'new' ischemic syndromes have been described. Within the 'new' ischemic syndromes, ventricular post-ischemic dysfunction--also known as 'stunned myocardium'--is worth mentioning. In this route, several studies have suggested that reperfusion per se could cause cellular injury (reperfusion injury). In previous years, a protective effect on the injury caused by ischemia and reperfusion in the heart has been attributed to adenosine. These effects have been documented in different experimental in vivo and in vitro models. Thus, the administration of exogenous adenosine, or agonists of adenosine receptors prior to ischemia reduces the size of the infarction, improves the recovery of the ventricular function during reperfusion (attenuating stunning) and prolongs the time period to the ischemic contracture. However, focusing on a potential therapeutic application, it is of the utmost importance to find this protection and learn the mechanisms involved when procedures are applied during early reperfusion. We showed that adenosine, administered from the beginning of reperfusion, attenuated systolic and diastolic (myocardial stiffness) alterations of the stunned myocardium. This protective effect was mediated by the activation of A1 adenosine receptors, and without modification on infarct size. According to some authors, adenosine can decrease the release of endothelin, during early reperfusion, and reduce an overload of Ca2+ that could cause a cellular lesion. Finally, ischemic preconditioning involves a series of intracellular events that are initiated with the activation of the A1 receptor, and end at the sensitive K+ ATP channels of the mitochondria. The phosphorylation and opening of these channels would cause the protective effect. Activation of this specific mechanism during reperfusion has not been studied extensively.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14575317

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  46 in total

Review 1.  Protective effects of adenosine in the reversibly injured heart.

Authors:  R D Lasley; R M Mentzer
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

Review 2.  The role of adenosine in the regulation of coronary blood flow.

Authors:  R M Berne
Journal:  Circ Res       Date:  1980-12       Impact factor: 17.367

3.  Extracellular action of adenosine and the antagonism by aminophylline on the atrioventricular conduction of isolated perfused guinea pig and rat hearts.

Authors:  L Belardinelli; R A Fenton; A West; J Linden; J S Althaus; R M Berne
Journal:  Circ Res       Date:  1982-11       Impact factor: 17.367

4.  [The activation of A1 adenosine receptors attenuates myocardial stunning in the rabbit].

Authors:  M Donato; C Morales; V D'Annunzio; O Scapín; R J Gelpi
Journal:  Medicina (B Aires)       Date:  2001       Impact factor: 0.653

5.  Blockade of adenosine receptors during ischaemia increases systolic dysfunction but does not affect diastolic creep in stunned myocardium.

Authors:  S E Rynning; E Hexeberg; S Birkeland; J Westby; K Grong
Journal:  Eur Heart J       Date:  1994-12       Impact factor: 29.983

6.  Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells.

Authors:  B N Cronstein; R I Levin; J Belanoff; G Weissmann; R Hirschhorn
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

7.  Activation of adenosine receptors before ischemia enhances tolerance against myocardial stunning in the rabbit heart.

Authors:  T Ogawa; T Miura; K Shimamoto; O Iimura
Journal:  J Am Coll Cardiol       Date:  1996-01       Impact factor: 24.094

Review 8.  Protective effects of adenosine in myocardial ischemia.

Authors:  S W Ely; R M Berne
Journal:  Circulation       Date:  1992-03       Impact factor: 29.690

9.  Adenosine protects ischemic and reperfused myocardium by receptor-mediated mechanisms.

Authors:  M F Janier; J L Vanoverschelde; S R Bergmann
Journal:  Am J Physiol       Date:  1993-01

10.  Adenosine and dipyridamole mimic the effects of ischemic preconditioning.

Authors:  S M Mosca; R J Gelpi; H E Cingolani
Journal:  J Mol Cell Cardiol       Date:  1994-10       Impact factor: 5.000

View more
  21 in total

Review 1.  G Protein-coupled Receptor Biased Agonism.

Authors:  Sima Y Hodavance; Clarice Gareri; Rachel D Torok; Howard A Rockman
Journal:  J Cardiovasc Pharmacol       Date:  2016-03       Impact factor: 3.105

2.  G protein-coupled receptors in cardiac biology: old and new receptors.

Authors:  Simon R Foster; Eugeni Roura; Peter Molenaar; Walter G Thomas
Journal:  Biophys Rev       Date:  2015-01-13

3.  A novel association of adenosine deaminase with paroxysmal atrial fibrillation: a propensity score analysis from a case-control study.

Authors:  Liang Liu; Yong-Ming He; Cui-Fen Hu; Xin Zhao; Hai-Feng Xu; Xiang-Jun Yang
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

4.  Separation of on-target efficacy from adverse effects through rational design of a bitopic adenosine receptor agonist.

Authors:  Celine Valant; Lauren T May; Luigi Aurelio; Chung Hui Chuo; Paul J White; Jo-Anne Baltos; Patrick M Sexton; Peter J Scammells; Arthur Christopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-11       Impact factor: 11.205

Review 5.  Cardiac GPCRs: GPCR signaling in healthy and failing hearts.

Authors:  Natasha C Salazar; Juhsien Chen; Howard A Rockman
Journal:  Biochim Biophys Acta       Date:  2007-02-20

Review 6.  Biased signalling: from simple switches to allosteric microprocessors.

Authors:  Jeffrey S Smith; Robert J Lefkowitz; Sudarshan Rajagopal
Journal:  Nat Rev Drug Discov       Date:  2018-01-05       Impact factor: 84.694

7.  Role of the cyclooxygenase pathway in the protection against postischemic stunning in conscious sheep.

Authors:  Elena C Lascano; Héctor F Del Valle; Jorge A Negroni
Journal:  Mol Cell Biochem       Date:  2006-05-12       Impact factor: 3.396

8.  Arginase inhibition improves coronary microvascular function and reduces infarct size following ischaemia-reperfusion in a rat model.

Authors:  J Grönros; A Kiss; M Palmér; C Jung; D Berkowitz; J Pernow
Journal:  Acta Physiol (Oxf)       Date:  2013-04-15       Impact factor: 6.311

Review 9.  G-Protein-Coupled Receptors in Heart Disease.

Authors:  Jialu Wang; Clarice Gareri; Howard A Rockman
Journal:  Circ Res       Date:  2018-08-31       Impact factor: 17.367

10.  2016 Philip S. Portoghese Medicinal Chemistry Lectureship: Designing Bivalent or Bitopic Molecules for G-Protein Coupled Receptors. The Whole Is Greater Than the Sum of Its Parts.

Authors:  Amy Hauck Newman; Francisco O Battiti; Alessandro Bonifazi
Journal:  J Med Chem       Date:  2019-09-24       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.